USING SIMULATED INDIVIDUAL PATIENT DATA (IPD) FROM PUBLISHED REGISTRY AND IPD FROM THE SEER-MEDICARE REGISTRY TO EXTRAPOLATE RESULTS FROM RANDOMISED CLINICAL TRIALS (RCTS) IN METASTATIC MELANOMA

Author(s)

Martina R¹, Jenkins D¹, Bujkiewicz S¹, Dequen P¹, Abrams KR¹, Lees M², Davies J³, Kalf R⁴, Makady A⁵
¹University of Leicester, Leicester, UK, ²Bristol-Myers Squibb, Paris, France, ³F. Hoffmann-La Roche AG, Basel, Switzerland, ⁴National Healthcare Institute (ZIN), Diemen, The Netherlands, ⁵The National Healthcare Institute (ZIN), Diemen, The Netherlands

Presentation Documents

PCN49--strong-u-martina-r-u-sup-1-sup-strong-jenkins-d-sup-1-sup-bujkiewicz-s-sup-1-sup-dequen-p-sup-1-sup-abrams-kr-sup-1-sup-lees-m-sup-2-sup-davies-j-sup-3-sup-kalf-r-sup-4-sup-makady-a-sup-5-sup-br-sup-1-sup-university-of-leicester-leic ...

OBJECTIVES:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCN49

Topic

Clinical Outcomes

Topic Subcategory

Relating Intermediate to Long-term Outcomes

Disease

Oncology

Explore Related HEOR by Topic

Clinical Outcomes

Presentation